Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
HYTN.CNthis companyHYTN Innovations Inc.	CA$0.12	-10.37×	-14.08×	9.42×	-15.64×	-164.3%	5.6%	-82.6%	-90.6%	135.4%	-131.8%	-3.7%	-1.82×	-1.52×	-9.63×	0.57×	0.0%	3	-11.81	2	C
AVNT.TOAvant Brands Inc.	CA$0.59	-0.91×	0.36×	0.25×	-1.65×	-15516.9%	-10.2%	-40.1%	-27.5%	-39.8%	-35.7%	63.9%	0.62×	-1×	-7.53×	1.62×	0.0%	4	-2.99	2	C
CRON.TOCronos Group Inc.	CA$5.13	-104.44×	0.92×	6.74×	-73.63×	-294.2%	41.4%	-12.0%	-6.4%	-0.9%	-0.3%	0.0%	0×	268.35×	0×	19.59×	0.0%	6	13.62	4	A-
DB.VDecibel Cannabis Company Inc.	CA$1.99	-21.57×	1.02×	0.56×	-9.27×	-169.4%	15.5%	-15.4%	-2.6%	-4.7%	-16.2%	8.6%	0.71×	-3.39×	-6.57×	1.34×	0.0%	2	1.5	1	C-
LOVE.TOCannara Biotech Inc.	CA$2.04	12.86×	1.63×	1.55×	6.8×	-112.9%	44.0%	20.7%	12.2%	12.8%	10.9%	8.2%	0.41×	0.96×	5.1×	2.4×	0.0%	7	2.95	4	A-
OGI.TOOrganigram Global Inc.	CA$1.25	-14.84×	1.03×	1.39×	-13.88×	-3094.3%	3.7%	-34.1%	-9.6%	-7.1%	-13.0%	-6.8%	0.03×	3.64×	0×	2.26×	0.0%	5	-0.07	4	A
Peer median	—	-14.84×	1.02×	1.39×	-9.27×	-294.2%	15.5%	-15.4%	-6.4%	-4.7%	-13.0%	8.2%	0.41×	0.96×	0×	2.26×	0.0%	5	1.5	4	—